scispace - formally typeset
K

Kathleen Sprouffske

Researcher at Novartis

Publications -  22
Citations -  1125

Kathleen Sprouffske is an academic researcher from Novartis. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 11, co-authored 21 publications receiving 790 citations. Previous affiliations of Kathleen Sprouffske include University of Pennsylvania & University of Zurich.

Papers
More filters
Journal ArticleDOI

Growthcurver: an R package for obtaining interpretable metrics from microbial growth curves.

TL;DR: Growthcurver summarizes the growth characteristics of microbial growth curve experiments conducted in a plate reader and is an easy-to-use R package available for installation from the Comprehensive R Archive Network (CRAN).
Journal ArticleDOI

Cancer in light of experimental evolution.

TL;DR: It is argued that enhanced prediction and control of cancer may be possible using ideas developed in the context of experimental evolution, and some prospects for future research at the interface between these traditionally separate areas are pointed out.
Journal ArticleDOI

Fast NMDA Receptor–Mediated Synaptic Currents in Neurons From Mice Lacking the ε2 (NR2B) Subunit

TL;DR: TheN-methyl-d-aspartate (NMDA) receptor has been implicated in the formation of synaptic connections and the role of the e2 (NR2B) NMDA receptor subunit, which is prominently expressed, is investigated.
Journal ArticleDOI

Animal Cell Differentiation Patterns Suppress Somatic Evolution

TL;DR: It is found that a mutation disrupting differentiation can create a new self-renewing cell population that is vulnerable to somatic evolution, which is relevant not only to the evolutionary origins of multicellularity, but also the causes of pathologies such as cancer and senescence in extant metazoans, including humans.
Journal ArticleDOI

High mutation rates limit evolutionary adaptation in Escherichia coli.

TL;DR: This work demonstrates that the mutation rate changes the global balance between deleterious and beneficial mutational effects on fitness, and suggests that this tipping point already occurs at the modest mutation rates that are found in the wild.